Earnings History Data for Centogene N.V. (CNTG) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Centogene N.V.

Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-07-2022	PM	0:00 AM ET (Jul 15)	CNTG	Centogene	0.00	-0.54	-0.56	0.00	Centogene GAAP EPS of -€0.28, revenue of €10.32M [7/15/2022 8:34 AM]	2.18	0.0 (0.00%)	0.0	0.0 (0.00%)	1.83 - 11.75	27,212	10,000	0
Centogene GAAP EPS of -€0.28, revenue of €10.32M [7/15/2022 8:34 AM] CENTOGENE Reports First Quarter 2022 Financial Results [Jul-15-22 08:15AM]
31-03-2022	PM	7:35 AM ET (Mar 30)	CNTG	Centogene N.V.	107.20	-0.58	0.00	0.21	Centogene reports Q4 results [3/30/2022 7:41 AM]	4.15	-0.01 (-0.24%)	4.44	0.28 (6.73%)	3.16 - 13.12	18,691	10,000	1,085
Centogene reports Q4 results [3/30/2022 7:41 AM] CENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-30-22 07:30AM] Centogene N.V. (CNTG) Q4 2021 Earnings Call Transcript [Mar-30-22 01:00PM]
24-11-2021	PM	6:35 AM ET (Nov 24)	CNTG	Centogene N.V.	199.20	-1.08	-0.59	-0.32	Centogene reports Q3 results [11/24/2021 7:39 AM]	7.25	-1.93 (-21.02%)	0.0	0.0 (0.00%)	6.76 - 14.00	213,586	20,000	0
Centogene reports Q3 results [11/24/2021 7:39 AM] CENTOGENE Reports Third Quarter 2021 Financial Results [Nov-24-21 07:35AM] Centogene N.V. (CNTG) Reports Q3 Loss, Tops Revenue Estimates [Nov-24-21 08:55AM]
07-09-2021	PM	6:30 AM ET (Sep 7)	CNTG	Centogene N.V.	234.09	-0.45	-0.26	-0.57		10.36	-0.18 (-1.71%)	11.60	1.06 (10.06%)	8.61 - 14.79	20,838	10,000	5,349
Centogene reports Q2 reaults [9/7/2021 6:48 AM] CENTOGENE Reports Second Quarter 2021 Financial Results [Sep-07-21 06:35AM] Centogene N.V. (CNTG) Reports Q2 Loss, Tops Revenue Estimates [Sep-07-21 07:55AM] Centogene N.V. (CNTG) Q2 2021 Earnings Call Transcript [Sep-07-21 04:00PM]
16-06-2021	PM	6:30 AM ET (Jun 16)	CNTG	Centogene N.V.	216.97	-0.27	-0.30	-0.47	Centogene reports Q1 results [6/16/2021 6:57 AM]	10.23	0.06 (0.59%)	10.50	0.33 (3.24%)	8.61 - 27.10	99,236	80,000	806
Centogene reports Q1 results [6/16/2021 6:57 AM] Centogene N.V. (CNTG) Stock Jumps 7.5%: Will It Continue to Soar? [Jun-15-21 08:14AM] CENTOGENE Reports First Quarter 2021 Financial Results in the Lead Up to Virtual Investor Event [Jun-16-21 06:30AM] Wednesdays Pre-Market: Heres What You Need to Know Before the Market Opens [Jun-16-21 08:00AM]
15-04-2021	PM	6:30 AM ET (Apr 15)	CNTG	Centogene N.v.	257.00	0.21	-0.09	0.00	Centogene beats on revenue [4/15/2021 6:44 AM]	11.55	-0.57 (-4.70%)	0.0	0.0 (0.00%)	9.25 - 27.10	31,245	40,000	0
Centogene beats on revenue [4/15/2021 6:44 AM] Centogene extends partnership with Takeda in diagnosis of genetic disorders [4/14/2021 6:35 AM] CENTOGENE Reports Record Fourth Quarter and Full Year 2020 Financial Results [Apr-15-21 06:30AM] CENTOGENE Extends Partnership With Takeda [Apr-14-21 06:30AM]
16-12-2020	PM	7:50 AM ET (Dec 16)	CNTG	Centogene N.V.	257.75	-0.32	-0.33	-14.45	Centogene reports Q3 results [12/16/2020 6:46 AM]	11.32	-0.17 (-1.48%)	12.24	0.75 (6.53%)	9.25 - 28.71	99,858	58,697	11,183
Centogene reports Q3 results [12/16/2020 6:46 AM] Centogene jumps 8% after Q3 top-line up 212%, raises FY20 guidance [12/16/2020 7:10 AM] Recap: Centogene Q3 Earnings [Dec-16-20 07:03AM] CENTOGENE Reports Third-Quarter 2020 Financial Results and Increases Full Year Guidance [Dec-16-20 06:30AM]
23-09-2020	PM	6:30 AM ET (Sep 23)	CNTG	Centogene N.V.	231.95	-0.57	-0.51	0.00		9.54	-1.51 (-13.67%)	11.12	0.07 (0.63%)	7.80 - 28.71	153,699	103,132	4,990

15-06-2020	PM	6:30 AM ET (Jun 15)	CNTG	Centogene N.V.	374.58	-0.47	-0.38	0.00	Centogene EPS misses by €0.12, misses on revenue [6/15/2020 6:35 AM]	18.99	-2.33 (-10.93%)	21.00	-0.32 (-1.50%)	7.80 - 28.71	16,534	8,526	1,890